GADD45A and blast phase chronic myelogenous leukemia, BCR-ABL1 positive: Notably, retrospective historical analysis of these patients revealed that all blast crisis patients that exhibited low levels of Gadd45a expression exhibited poor response to all forms of therapy resulting in the demise of most of these patients (data not shown).